German pharma firm’s IP scheme ‘avoided billions in tax’

US senator lays into big pharma over ‘Republican-enabled’ tax schemes | Patents for cancer treatment Keytruda allegedly moved offshore.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

How AI will be shaped by legal and regulatory developments in 2026

9 January 2026 Traceability and transparency of training practices, and the value of bespoke tool, are among the key AI trends that will be shaped by legal and regulatory developments in 2026, write experts from Rouse.

Europe

Deadline extended: Who are the world’s best in-house counsel?

9 January 2026 A first-of-its-kind project by sister title WIPR aims to highlight the world’s leading in-house intellectual property counsel—and it needs your help.

Careers

‘All voices must be heard’: New CIPA president sets out plans for 2026

9 January 2026 Simon Wright says he will focus on engagement with in-house and SME members, as well as support the UK rejoining the UPC and more as he takes the reins at the Chartered Institute of Patent Attorneys.

More features

Deadline extended: Who are the world’s best in-house counsel?

‘All voices must be heard’: New CIPA president sets out plans for 2026

Insulin pump rivals face off in major trade secrets dispute hearing

Bayer enters COVID-19 vaccine row with three suits against major drugmakers

Arnold & Porter loses another regulatory partner to growing rival

CIPA’s outgoing president: UK rejoining the UPC needs ‘support from business’

Merchant & Gould hires 13 attorneys to open new Boston office

Novo Nordisk secures China win ahead of key patent expiration

German pharma firm’s IP scheme ‘avoided billions in tax’

More on this story

Editor's picks

Editor's picks

More features